臨床学会レポート：コロナワクチンが心臓に与える影響

この先どうなるのだろうか・・・・

治療方法が見つかるといいのだけど・・・成分も非公開のワクチンの治療方法を見つけるのは困難だろうな。現状では製薬会社がワクチンの一部成分を公開しているのみで、幾つかの特許関連、その他重要成分は非公開である・・・・

しばらくは民間療法に頼るしかないのか・・・

これを皮切りに心臓以外への影響も続けて報告され始めるといいが・・・少しでも早く有効な治療を始めて頂きたい・・・被害が拡大しすぎる前に

mRNAワクチンは第4相臨床試験中：2023年5月終了

----引用------------------------------------------------------------------------------

2021年11月20日、第4回日本最先端臨床医学学会、大阪市立大学名誉教授：猪上正康氏の講演

A Report from the Japanese Cutting-edge Clinical Medicine Conference Claims Genetic Vaccines are Toxic

On November 20, local time, the fourth academic conference of the Japanese Cutting-edge Clinical Medicine was held in Tokyo. On November 21 at the meeting, Mr. INOUE MASAYASU, professor emeritus of Osaka City University, addressed a lecture on the Covid-19 virus, a.k.a Chinese Communist Party (CCP) virus, and the CCP virus vaccine, drawing great attention from the attendees.

Prof. MASAYASU’s research revealed that the CCP virus actually causes blood clots, with pneumonia as a secondary symptom since the S protein acts as a blood clot toxin. In 1233 vaccine-related deaths, blood clots and circulatory disorders are typically to blame. The DNA vaccine is a genetically modified, semi-permanent active vaccine, and the mRNA vaccine is deposited in the adrenal glands and ovaries.

In Professor MASAYASU’s report, he stated people who have Covid-19 virus asymptomatic infection can acquire immune memory, so Japanese patients present ADE antibodies. He, therefore, concludes that vaccinating children and people of childbearing who are not at risk of the CCP virus is a crazy decision.

-------------------------------------------------------------------------------------

米国心臓学会AHA: ファイザー、モデルナのコロナワクチンの心臓への影響を報告した論文

https://www.ahajournals.org/doi/abs/10.1161/circ.144.suppl_1.10712

Mrna COVID Vaccines Dramatically Increase Endothelial Inflammatory Markers and ACS Risk as Measured by the PULS Cardiac Test: a Warning

Abstract

Our group has been using the PLUS Cardiac Test (GD Biosciences, Inc, Irvine, CA) a clinically validated measurement of multiple protein biomarkers which generates a score predicting the 5 yr risk (percentage chance) of a new Acute Coronary Syndrome (ACS). The score is based on changes from the norm of multiple protein biomarkers including IL-16, a proinflammatory cytokine, soluble Fas, an inducer of apoptosis, and Hepatocyte Growth Factor (HGF)which serves as a marker for chemotaxis of T-cells into epithelium and cardiac tissue, among other markers. Elevation above the norm increases the PULS score, while decreases below the norm lowers the PULS score.The score has been measured every 3-6 months in our patient population for 8 years. Recently, with the advent of the mRNA COVID 19 vaccines (vac) by Moderna and Pfizer, dramatic changes in the PULS score became apparent in most patients.This report summarizes those results. A total of 566 pts, aged 28 to 97, M:F ratio 1:1 seen in a preventive cardiology practice had a new PULS test drawn from 2 to 10 weeks following the 2nd COVID shot and was compared to the previous PULS score drawn 3 to 5 months previously pre- shot. Baseline IL-16 increased from 35=/-20 above the norm to 82 =/- 75 above the norm post-vac; sFas increased from 22+/- 15 above the norm to 46=/-24 above the norm post-vac; HGF increased from 42+/-12 above the norm to 86+/-31 above the norm post-vac. These changes resulted in an increase of the PULS score from 11% 5 yr ACS risk to 25% 5 yr ACS risk. At the time of this report, these changes persist for at least 2.5 months post second dose of vac.We conclude that the mRNA vacs dramatically increase inflammation on the endothelium and T cell infiltration of cardiac muscle and may account for the observations of increased thrombosis, cardiomyopathy, and other vascular events following vaccination.

----引用終---------------------------------------------------------------------------